دورية أكاديمية
Survival for oesophageal, stomach and small intestine cancers in Europe 1999–2007: Results from EUROCARE-5
| العنوان: | Survival for oesophageal, stomach and small intestine cancers in Europe 1999–2007: Results from EUROCARE-5 |
|---|---|
| المؤلفون: | Anderson, L.A., Tavilla, A., Brenner, H., Luttmann, S., Navarro, C., Gavin, A.T., Holleczek, B., Johnston, B.T., Cook, M.B., Bannon, F., Sant, M., Jonasson JG |
| المساهمون: | 1 Queens Univ Belfast, Sch Med Dent & Biomed Sci, Ctr Publ Hlth, Belfast BT12 6BJ, Antrim, North Ireland 2 Italian Natl Inst Hlth, Natl Ctr Epidemiol, Rome, Italy 3 German Canc Res Ctr, Div Clin Epidemiol & Aging Res, Heidelberg, Germany 4 German Canc Res Ctr, Div Prevent Oncol, Heidelberg, Germany 5 German Canc Res Ctr, German Canc Consortium DKTK, Heidelberg, Germany 6 Leibniz Inst Prevent Res & Epidemiol BIPS, Bremen Canc Registry, Bremen, Germany 7 IMIB Arrixaca, Murcia Reg Hlth Council, Dept Epidemiol, Murcia, Spain 8 CIBERESP, Madrid, Spain 9 Univ Murcia, Dept Hlth & Social Sci, Murcia, Spain 10 Queens Univ Belfast, Northern Ireland Canc Registry, Belfast BT12 6BJ, Antrim, North Ireland 11 Saarland Canc Registry, D-66119 Saarbrucken, Germany 12 Belfast Hlth & Social Care Trust, Belfast, Antrim, North Ireland 13 NCI, Div Canc Epidemiol & Genet, NIH, Bethesda, MD 20892 USA 14 Fdn IRCCS Ist Nazl Tumori, Analyt Epidemiol & Hlth Impact Unit, Dept Prevent & Predict Med, I-20133 Milan, Italy |
| بيانات النشر: | Elsevier SCI |
| سنة النشر: | 2016 |
| المجموعة: | Hirsla - Landspítali University Hospital research archive |
| مصطلحات موضوعية: | Esophageal Neoplasms, Stomach Neoplasms, Duodenal Neoplasms, Ileal Neoplasms, Jejunal Neoplasms, Survival, Europe |
| الوصف: | To access publisher's full text version of this article click on the hyperlink at the bottom of the page ; Background: European regional variation in cancer survival was reported in the EUROCARE-4 study for patients diagnosed in 1995-1999. Relative survival (RS) estimates are here updated for patients diagnosed with cancer of the oesophagus, stomach and small intestine from 2000 to 2007. Trends in RS from 1999-2001 to 2005-2007 are presented to monitor and discuss improvements in patient survival in Europe. Materials and methods: EUROCARE-5 data from 29 countries (87 cancer registries) were used to investigate 1- and 5-year RS. Using registry-specific life-tables stratified by age, gender and calendar year, age-standardised 'complete analysis' RS estimates by country and region were calculated for Northern, Southern, Eastern and Central Europe, and for Ireland and United Kingdom (UK). Survival trends of patients in periods 1999-2001, 2002-2004 and 2005-2007 were investigated using the 'period' RS approach. We computed the 5-year RS conditional on surviving the first year (5-year conditional survival), as the ratio of age-standardised 5-year RS to 1-year RS. Results: Oesophageal cancer 1- and 5-year RS (40% and 12%, respectively) remained poor in Europe. Patient survival was worst in Eastern (8%), Northern (11%) and Southern Europe (10%). Europe-wide, there was a 3% improvement in oesophageal cancer 5-year survival by 2005-2007, with Ireland and the UK (3%), and Central Europe (4%) showing large improvements. Europe-wide, stomach cancer 5-year RS was 25%. Ireland and UK (17%) and Eastern Europe (19%) had the poorest 5-year patient survival. Southern Europe had the best 5-year survival (30%), though only showing an improvement of 2% by 2005-2007. Small intestine cancer 5-year RS for Europe was 48%, with Central Europe having the best (54%), and Ireland and UK the poorest (37%). Five-year patient survival improvement for Europe was 8% by 2005-2007, with Central, Southern and Eastern Europe showing the greatest ... |
| نوع الوثيقة: | article in journal/newspaper |
| اللغة: | English |
| تدمد: | 09598049 |
| العلاقة: | http://linkinghub.elsevier.com/retrieve/pii/S0959804915007066Test; Survival for oesophageal, stomach and small intestine cancers in Europe 1999–2007: Results from EUROCARE-5 2015, 51 (15):2144 European Journal of Cancer; http://hdl.handle.net/2336/614559Test; European Journal of Cancer |
| DOI: | 10.1016/j.ejca.2015.07.026 |
| الإتاحة: | https://doi.org/10.1016/j.ejca.2015.07.026Test http://hdl.handle.net/2336/614559Test |
| حقوق: | Archived with thanks to European Journal of Cancer ; National Consortium - Landsaðgangur |
| رقم الانضمام: | edsbas.EB4DDAD3 |
| قاعدة البيانات: | BASE |
| تدمد: | 09598049 |
|---|---|
| DOI: | 10.1016/j.ejca.2015.07.026 |